"ResApp has received a significant amount of interest in the use of its smartphone-based diagnostic technology for the triage of COVID-19 patients and is in detailed discussions with a number of healthcare systems, including in the UK, regarding specific COVID-19 implementations and studies using ResAppDx-EU to triage patients with respiratory symptoms and prioritise patient access to over-burdened clinics"
“We are seeing significant growth in the adoption of new digital technologies across the region’s healthcare systems. The UK’s National Health Service is pursuing multiple initiatives using digital technology to transform healthcare and last year announced that telehealth would be a standard of care in the UK within five years. In 2019, Germany introduced the Digital Supply Law to expand the use of telehealth. It is clear that the COVID-19 pandemic is accelerating this transition to digital-first healthcare"
As horrible as the global pandemic is, it has no doubt accelerated the interest/uptake in telehalth and RAP, and is looking like it will be the catalyst needed for this company to achieve its potential. Delivering better health outcomes globally and a great ROI for shareholders. Well done Tony and the team and well done to LTH for sticking fat - and keep spruiking its benefits to anyone who will listen.
"ResApp has received a significant amount of interest in the use...
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #